drugset / Trial / NCT05992428
Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, 2-Part, phase 1 study to evaluate drug interactions when DA-8010 is co-administered with Paroxetine or Mirabegron in healthy adult subjects
Timeline
- Start
- 2023-08-22
- Primary completion
- 2023-11-07
- Completion
- 2023-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 50 mg | — |
| Subject | Paroxetine | Small molecule | 20 mg | — |
| Subject | VELUFENACIN | Small molecule | 5 mg | — |
Indications
No indication recorded.